Asthma Drug Facility

Download the PDF

Any client of the ADF must agree to the following terms when signing the Technical Agreement :

1. The client is required to read all the information on ‘Placing your order' on the ADF website.
2. ADF medicines can only be purchased for use in low and middle income countries (as determined by the World Bank classification and listed on the ADF website).
3. Inhaled corticosteroids supplied by the ADF will be used according to international guidelines for the diagnosis and treatment of asthma (as adapted to national/local conditions).
4. ADF will monitor the use of inhaled corticosteroids. The client is required to submit to the ADF routine monitoring reports for all patients who receive the inhaled corticosteroids purchased through the ADF. The client is required to identify a person responsible for submitting these reports.
5. The client agrees, in principal, to a possible site visit by the ADF technical team for assessment of quality of services.
6. The client is responsible for medicines beyond the agreed point of delivery. This includes importation procedures.
7. One of ADF's objectives is to improve access to medicines. The client is expected to sell them with a minimal mark-up or to provide them free-of-charge to patients.
8. Exportation or re-selling of medicines is forbidden and will lead to legal sanctions.
9. The client is required to make a full advance payment to ADF (by bank transfer or letter of credit from a bank) before the order can be confirmed and the medicines shipped to their country.